{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:624e65f2-f469-4c4b-bf83-dbebc6558202", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-25T20:49:48.668258Z", "firstcreated": "2026-10-25T20:45:18.484112Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Researchers question methods behind NIMBLE trial on myasthenia gravis drugs", "byline": "Kelsey Sawyer", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Science Official”. Set rel=canonical to https://scienceofficial.org/medicine/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs/ when publishing on the web.", "description_text": "Letter to The Lancet says the NIMBLE trial of complement-blocking therapies for generalised myasthenia gravis raises three unresolved methodological questions, even though the finding that partial blockade may suffice is potentially important.", "altids": {"mosaic": "624e65f2-f469-4c4b-bf83-dbebc6558202", "story": "16a5e126-f583-4c83-a336-8c73e8347528", "slug": "researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs"}, "subject": [{"name": "Science", "rel": "direct", "literal": "science", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:288134f3-35d1-4222-80d7-5683152842f8", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "[Correspondence] Unanswered questions from the NIMBLE trial", "description_text": "Researchers question methods behind NIMBLE trial on myasthenia gravis drugs", "copyrightholder": "commons.wikimedia.org", "copyrightnotice": "David P Howard", "usageterms": "Open licence: the credit line must travel with the file.", "altids": {"wireva": "288134f3-35d1-4222-80d7-5683152842f8"}, "extra": {"wireva:delivery_mode": "file", "wireva:rights": {"licence": "CC BY-SA 2.0", "licence_url": "https://creativecommons.org/licenses/by-sa/2.0/", "licence_raw": "CC BY-SA 2.0", "licence_verified_at": "2026-10-25T20:49:48.690236Z", "attribution_required": true, "attribution_text": "David P Howard", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": true}, "wireva:provenance": {"creator": "", "source_name": "commons.wikimedia.org", "source_url": "https://commons.wikimedia.org/wiki/File:Medical_Research_Council,_Laboratory_of_Molecular_Biology_-_geograph.org.uk_-_3018493.jpg", "source_page_url": "https://commons.wikimedia.org/wiki/File:Medical_Research_Council,_Laboratory_of_Molecular_Biology_-_geograph.org.uk_-_3018493.jpg", "our_page_url": "https://scienceofficial.org/medicine/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs/"}, "wireva:role": "lead"}, "renditions": {"original": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/79684d8cfb82515fa28d9df0e292c85513c02671de1e94064741afcf8cbfb99f.jpg", "mimetype": "image/jpeg", "width": 1200, "height": 900, "sizeinbytes": 278749}, "source": {"href": "https://commons.wikimedia.org/wiki/File:Medical_Research_Council,_Laboratory_of_Molecular_Biology_-_geograph.org.uk_-_3018493.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:16a5e126-f583-4c83-a336-8c73e8347528", "slug": "researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs-20261025", "status": "developing", "languages": ["en"], "item_count": 1, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/medicine/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_verified", "needs_review": false}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "passed", "score": 0.17, "checked_at": "2026-10-25T20:49:48.686529Z"}}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/medicine/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/624e65f2-f469-4c4b-bf83-dbebc6558202", "html": "https://wireva.mib.news/item/624e65f2-f469-4c4b-bf83-dbebc6558202/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs/", "story": "https://wireva.mib.news/story/researchers-question-methods-behind-nimble-trial-on-myasthenia-gravis-drugs-20261025/"}, "wireva:metrics": {"word_count": 315, "char_count": 2200, "reading_time_seconds": 157}}}